So H. Kwon
Incheon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications
Histone deacetylases in cancer metabolic reprogramming.
Journal: Experimental & molecular medicine
Published: January 30, 2026
Ubiquitin-mediated stabilization of KDM5B drives chemoresistance via repression of dual-specificity phosphatase 4 in ovarian cancer.
Journal: Signal transduction and targeted therapy
Published: August 01, 2025
Histone demethylase KDM4C confers temozolomide resistance to glioblastoma cells by epigenetically regulating E2F6.
Journal: Archives of pharmacal research
Published: May 25, 2025
MCC in the spotlight: Its dual role in signal regulation and oncogenesis.
Journal: Cellular signalling
Published: January 24, 2025
HDAC6 and USP9X Control Glutamine Metabolism by Stabilizing GS to Promote Glioblastoma Tumorigenesis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 23, 2025
Enhancement of renal fibrosis in PHF20 transgenic mice.
Journal: Toxicological research
Published: July 21, 2024
Exploring the various functions of PHD finger protein 20: beyond the unknown.
Journal: Toxicological research
Published: June 05, 2024
Discovery of organosulfur-based selective HDAC8 inhibitors with anti-neuroblastoma activity.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: June 05, 2024
The mutated in colorectal cancer (MCC) gene can serve as a potential biomarker of glioblastoma.
Journal: Frontiers in oncology
Published: May 20, 2024
Overview of carboxyl‑terminal modulator protein 1 and its importance in various metabolic regulations (Review).
Journal: Molecular medicine reports
Published: March 14, 2024
Epigenetic roles of KDM3B and KDM3C in tumorigenesis and their therapeutic implications.
Journal: Cell death & disease
Published: December 20, 2023
Last Updated: 09/26/2026